Drug-Free Nanoparticles Could Reshape Future Cancer Therapies
Prof. Assaf Zinger's team at Technion Israel developed drug-free MPsomes, slowing aggressive breast cancer tumors in preclinical models by altering the immune.
Prof. Assaf Zinger's team at Technion Israel developed drug-free MPsomes, slowing aggressive breast cancer tumors in preclinical models by altering the immune.